To determine TB prevalence at entry, screening yield and incidence in immigrants on a TB health undertaking (TBU) who were selected for post-migration screening due to an abnormal chest radiograph (CXR) in Victoria, Australia, in the years 1996-2006.
gramme) was 420/100 000, and incidence (cases notified between 6 and 12 months after screening registration date) was 160/100 000 person-years. Persons issued a TBU after applying from within Australia (on-shore) had a prevalence of 1876/100 000, seven-fold higher than those issued a TBU outside Australia (off-shore, 254/100 000). The combination of an abnormal CXR and a tuberculin skin test ⩾ 15 mm carried a prevalence of notified TB of 2907/100 000.
C O N C L U S I O N :
Selective post-migration screening can achieve a high yield of notified TB. K E Y W O R D S : tuberculosis; immigration; screening THE INCIDENCE of notifi ed tuberculosis (TB) in Australia is 5.4 per 100 000 persons per year; 86% of notifi ed cases occur in persons born overseas. Notification of active TB is mandatory. 1 In 2009, Australia issued 186 421 permanent visas and 4.0 million temporary entry visas, of which 3.3 million were visitors and 320 368 were overseas students. The State of Victoria received 24.5% permanent visa applications, 18.3% visitors and 33.1% students. The top three countries of birth for permanent additions to the Victorian population were India, the Peoples' Republic of China and the United Kingdom. Overseas students in Victoria have increased from 46 401 in 2004 to 117 711 in 2009. 2 People who want to migrate permanently or stay in Australia temporarily must satisfy the health requirement specifi ed in the Migration Regulations of the Australian Government. Applicants for permanent entry are asked to undergo a medical examination and chest X-ray (CXR) if aged ⩾11 years. Where CXRs show possible evidence of TB, the applicant is asked to provide sputum for smear and culture, and may be asked to provide serial CXRs over 3-6 months. If active TB is found, Australian migration law does not allow a visa to be granted until the person has undergone treatment and is declared free of active TB. This is documented by repeat CXR and sputum examination. If CXRs show evidence of previous but now inactive TB, the applicant may be asked to sign a TB health undertaking (TBU) at the time the visa is granted. By signing the TBU, the applicant agrees to contact the Health Undertaking Service on a free call number on arrival in Australia. The applicant also agrees to report to a State or Territory health authority for follow-up, as directed by the Health Undertaking Service. 3, 4 Applicants for temporary entry may be asked to undergo a CXR, medical examination and possibly further tests, including sputum examination and repeat CXR, depending on the length of intended stay in Australia and the TB risk rating of the applicant's country. 5 Most TBUs originate from visa applications lodged outside Australia (off-shore TBU), with a smaller number from inside Australia (on-shore TBU). Both off-shore and on-shore TBUs include permanent and temporary residency immigrants, refugees and other humanitarian entrants. 6 Under arrangements with the Department of Health Victoria (DH), the Department of Respiratory and Sleep Disorders Medicine at Western Hospital (WH) has provided post-migration screening for TB
S U M M A R Y
Post-migration screening for TB 51 in Victoria since 1996. Since 2001, all TBU appointments in Victoria have been arranged by the WH. Urgent appointments are available for the small proportion of on-shore TBUs where the CXR report suggests active TB (urgent on-shore TBU). Migrants are seen in the Migrant Screening Clinic for clinical review with their previous migration medical papers and CXR. The CXR is repeated at the clinic if a previous one is considered abnormal or of poor quality. Clinic doctors use a coded worksheet to record clinical information, which is entered into a clinic database. Selected migrants aged <35 years 7 are offered tuberculin skin testing (TST), including those with abnormal CXR, refugees 8 and those born in the high-burden countries whose migrants have the highest TB incidence in Victoria. 9, 10 TST is performed with 10 international units (IU) of tuberculin purifi ed protein derivative (human) 100 IU/ml (Commonwealth Serum Laboratories, Parkville, VIC, Australia). Most TSTs are read at 72 h; however, some are read at 96 h to provide TST at all clinics. 11 The clinic acts as a triage service, seeing each person once and referring those who need further assessment to other health services. Persons with symptoms suggestive of TB, or one or more CXRs suggestive of active TB, are defi ned as suspected active TB and referred to other specialist clinics. Those without such features, but with a history of TB diagnosis, positive TST or one or more CXRs thought likely to represent previous TB, are defi ned as inactive TB. Migrants with a positive TST are referred for treatment of latent TB infection at the discretion of the clinic physician. Those aged >35 years thought to have inactive TB are either discharged or referred for further radiographic surveillance, depending on the extent of the radiographic abnormality and the period of radiographic observation already undertaken. Any person with CXR suggestive of TB and less than 6 months' radiographic observation is also referred. The remaining persons are defi ned as either normal or an abnormal CXR due to a non-TB problem. Persons who do not attend an appointment are notifi ed to the Australian Government to check for a change of address. The Victorian Government TB programme is advised of non-attendees with CXRs suggestive of active TB; TB programme nurses are asked to contact the person, and may make a home visit.
Improved data are needed to guide the screening of migrants for TB. 12 The objectives of this report are to determine screening yield and prevalence at entry of notifi ed TB in migrants on a TBU.
STUDY POPULATION AND METHODS

Study population
The study includes all persons referred to the Migrant Screening Clinic at WH during the period from November 1996 to June 2006.
Matching of notified cases
Cases of notifi ed TB in subjects referred to WH on a TBU were identifi ed by linking the Migrant Screening Database at the WH with the DH database of notifi ed TB. For the period from November 1996 to May 2003, a computer-generated search was used to identify records with an identical date of birth in the two databases. These pairs of records were then manually checked for similar names, sex, country of origin and date of arrival. A further search, using the initial characters of family and given names combined with year of birth, was used to identify additional matching rec ords with differing dates of birth. From June 2003 until June 2007, the DH manually searched the WH Migrant Screening Clinic database on a weekly basis to match newly notifi ed cases of active TB.
Review of case records
For each matched case, the medical record of the Migrant Screening Clinic, including correspondence received from specialist clinics to which the migrant had been referred, was reviewed to determine whether the diagnosis of notifi ed TB was related to the activities of the TBU program. Cases diagnosed as a result of referral by the Migrant Screening Clinic were regarded as being found by the TBU program (Group A). Cases diagnosed after discharge from the Migrant Screening Clinic (Group B) or while on a TBU but not as a result of a screening referral (Group C), were regarded as not being found as a result of the TBU program.
Exclusions
Cases of notifi ed TB were excluded (Group D) if the diagnosis was made in Australia before a TBU was issued, or if the case had been transferred to WH from another provider of screening services. Cases diagnosed and treated before arrival in Australia do not appear in the DH database.
Definitions
Prevalence at entry was defi ned as the number of cases of TB notifi ed between arrival in Australia and 6 months after registration at WH per 100 000 persons. Screening yield at entry was defi ned as the number of notifi ed cases found by the screening programme (Group A) between arrival and 6 months after registration per 100 000 persons. Incidence was calculated as the number of cases notifi ed between 6 and 12 months after registration per 100 000 person-years.
Statistical analysis
Time between registration date and notifi cation date was computed using Epi Info v3.5 (Centers for Disease Control and Prevention, Atlanta, GA, USA). Where a migrant had applied for entry and a TBU issued on more than one occasion, only the fi rst TBU referred to WH was used in the analysis. Rates are expressed with 95% confi dence intervals (CIs). 13 
Ethics approval
The study was approved by the Ethics Committee of the Department of Health Victoria, and by the Human Research Ethics Committee of the Royal Melbourne Hospital Research Foundation.
RESULTS
Screening programme evaluation
Matching of DH and WH databases yielded 131 notifi ed prevalent cases, shown by diagnostic group in Table 1 . Thirty-six cases were excluded (26 on-shore, 10 off-shore). After exclusions, there were 95 persons with notifi ed TB among 18 801 persons registered, giving a prevalence at entry of 505/100 000 (95%CI 413-618). Of the 95 cases, 79 (83%) were notifi ed as a result of the screening programme, giving a yield at entry of 420/100 000 (337-524). The screening programme detected 89% (66/74) of cases of pulmonary TB compared to 62% (13/21) of cases with extrapulmonary disease (χ 2 = 10.2, P = 0.006). Of the 95 cases, 68 (71.6%) were diagnosed on culture, 4 (4.2%) on microscopy (culture-negative), 2 (2.1%) on histology, 2 (2.1%) on polymerase chain reaction 14 and 19 (20.0%) on radiology. Persons with notifi ed TB were younger (mean age 30.1 years) than persons not notifi ed (mean age 40.7 years). Prevalence was 595/ 100 000 (458-773) in men and 415 (303-568) in women (rate ratio 1.43, P = 0.08).
Off-shore/on-shore status was recorded for 13 025 persons. Prevalence was higher in on-shore than in off-shore TBUs ( Table 2 ). The majority of on-shore cases (42/52, 80.8%) were identifi ed among the urgent on-shore TBUs. Country of birth was recorded for 14 982 persons ( Table 3 ). The proportion of persons from high-burden countries was slightly lower (55.3%) among on-shore TBUs (urgent and nonu rgent combined) than off-shore TBUs (60.6%). The mean age of on-shore TBUs (39.3 years) was slightly lower than off-shore TBUs (41.0 years).
Clinic assessment
Following initial registration, 18 359 persons were given appointments at WH, 340 with regional physicians and 102 at the Royal Children's Hospital.
Of the 18 359 persons issued an appointment at the WH, 15 352 (83.6%) attended. CXR fi ndings were entered into the database for 14 866 persons, 3689 also had TST results entered and a clinic assessment was entered for 14 873 (Tables 4 and 5 ). Of those attending the clinic, 3022 (19.7%) were referred to specialist clinics for further assessment. Only 65% (9668/14 866) of CXRs were considered abnormal when reviewed or repeated in the clinic. The proportion considered abnormal was higher among onshore TBUs (1636/2168, 76%) than off-shore TBUs (5309/7948, 67%). 
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Incidence There were 15 cases notifi ed between 6 and 12 months after registration, giving an incidence of 160/100 000 (97-266) person-years.
DISCUSSION
Service models for screening new immigrants for TB appear to vary in Western Europe: few output data are routinely and systematically collected, 15 and identifying best practice in screening migrants for TB is diffi cult. 16 As this study examines those migrants arriving in Victoria who have been selected for community postmigration screening through the Health Undertaking System, it is not surprising that the yield of notifi ed TB is considerably higher than the estimated yield of 80/100 000 for the Australian migration screening programme as a whole. 17 The prevalence of notifi ed TB in this study (505/100 000) is similar to that reported in a study of migrants on TBU in Western Australia, 18 which found four cases among 1344 migrants in the fi rst 6 months (298/100 000).
The striking fi nding in this study is that the prevalence of notifi ed TB in on-shore TBUs is seven-fold higher than in off-shore TBUs. We consider several possible factors. A likely explanation is that cases of active TB prevalent at off-shore CXR complete treatment before arrival in Australia, are not notifi ed in Victoria, and are therefore not counted as active cases in this study, whereas active cases prevalent at onshore CXR are included as notifi ed cases in our data. Among on-shore applicants for visa renewal, ⩾2 years may have elapsed since the previous off-shore or onshore CXR, during which time new prevalent cases might accumulate. As the proportion of CXRs considered abnormal on clinic review was not greatly different in on-shore (76%) and off-shore (67%) TBUs, it seems unlikely that the seven-fold difference in the rate of notifi ed TB is due to a difference in image quality or reporting of CXRs, although we cannot exclude this as a contributory factor. TB incidence in the country of birth is known to predict TB risk in migrants, 1, [19] [20] [21] but this is an unlikely explanation, as the proportion of on-shore TBUs born in a high-burden country was slightly lower than the proportion of off-shore TBUs. The high prevalence in on-shore TBUs is not explained by the excluded cases, most of which were on-shore TBUs. On-shore applicants include asylum seekers, who have not had a pre-migration CXR. Visa class was not recorded in the database, but in 2008-2009, on-shore asylum seekers accounted for only 1.0% (564/54 810) of permanent additions to the Victorian population. 2 Orr et al. reported a much higher yield of active TB (2797/100 000 at fi rst visit) in a study of Canadian immigrants placed on post-migration surveillance after pre-migration health assessment. 22 The Canadian study included humanitarian entrants with a ministerial permit, which provides exemption from pre-migration health requirements. When humanitarian entrants on a permit are excluded, the yield is 1185/100 000. In the Canadian study, 98% of CXRs were abnormal; the Canadian yield can thus be compared with prevalence in this study among migrants with an abnormal CXR (776/100 000).
A recent national study of community postm igration screening from the Netherlands reported an overall prevalence of 131/100 000. 23 The prevalence among immigrants with abnormal CXRs was much higher (5185/100 000) than seen in this study, perhaps due to the absence of pre-migration screening. A study of applicants for migration to Australia at pre-migration screening found a yield of bacteriologically confi rmed TB of 489/100 000 in Viet Nam and 1209/100 000 in Cambodia. 24 Arshad et al. reported a yield of 349 active cases per 100 000 immigrants screened at entry in a meta-analysis that excluded studies only of immigrants who had undergone pre-migration screening. 25 Although almost all TBUs are issued because a CXR is thought to be abnormal, we found that only 65% of CXRs were considered abnormal when reviewed or repeated in the clinic, compared with 79% reported by Pang et al. in Western Australia, 18 and 98% in a similar post-migration programme in Canada. 22 We note three limitations of this study. The migrant screening data set is incomplete, we do not know what proportion of the persons registered r emained in Victoria, and we are unable to calculate incidence beyond 12 months. Furthermore, the probability of a CXR abnormality representing TB was not recorded separately from the overall clinic assessment, which could be helpful in further risk stratifi cation. 26, 27 
CONCLUSIONS
Migrants entering Victoria on a TBU have a high prevalence of active TB, and the Migrant Screening Clinic has a high yield at entry. We recommend continued selective post-migration screening for TB. Only 65% of persons on a TBU were thought to have abnormal CXR. We recommend that consideration be given to more selective issue of TBUs, and that further study be made of the high prevalence of notifi ed TB in on-shore TBUs. Se calcularon las tasas de TB notificada mediante la correlación entre la base de datos de un programa de detección y la base de datos de TB del estado de Victoria. R E S U LTA D O S : La prevalencia de TB al ingreso al país fue 505 por 100 000 (casos notificados entre el momento de la llegada a Australia y 6 meses después de la fecha de registro de la detección sistemática). El rendimiento diagnóstico a la entrada fue 420/100 000 (casos prevalentes detectados por el programa de detección sistemática). La incidencia fue 160/100 000 años-persona (casos notificados entre 6 y 12 meses después de la fecha de registro de la detección). Las personas que acordaron parti cipar en la iniciativa sanitaria sobre la TB después de solicitar un visado estando en Australia presentaron una prevalencia de 1876/100 000, la cual fue siete veces superior a la prevalencia de quienes solicitaron el visado y acordaron participar en la iniciativa estando fuera de Australia (254/100 000). La combinación de una CXR anormal y un resultado de la prueba tuberculínica ⩾15 mm aportó una notificación de la prevalencia de TB de 2907/100 000. C O N C L U S I Ó N : Una detección selectiva de la TB posterior a la inmigración puede lograr un alto rendimiento en la notificación de casos de TB.
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